PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29253907-6	2017	DipA increased the number of CXCR4+ MNCs residing in the infarcted Eng+/- hearts (Eng+/- 73.17+-12.67 vs. Eng+/- treated 157.00+-11.61, P = 0.0003) and significantly reduced infarct size (Eng+/- 46.60+-9.33% vs. Eng+/- treated 27.02+-3.04%, P = 0.03).	diprotin A	0-4	chemokine (C-X-C motif) receptor 4	Mus musculus	29-34	
21752744-4	2011	METHODOLOGY/PRINCIPAL FINDINGS: After surgically induced ligation of the LAD, SDF-1/CXCR4 interactions were specifically blocked by the CXCR4 receptor antagonist AMD3100 in G-CSF and Diprotin A treated C57BL/6 mice.	diprotin A	183-193	chemokine (C-X-C motif) receptor 4	Mus musculus	84-89	
21752744-4	2011	METHODOLOGY/PRINCIPAL FINDINGS: After surgically induced ligation of the LAD, SDF-1/CXCR4 interactions were specifically blocked by the CXCR4 receptor antagonist AMD3100 in G-CSF and Diprotin A treated C57BL/6 mice.	diprotin A	183-193	chemokine (C-X-C motif) receptor 4	Mus musculus	136-141	
18515407-6	2008	Preincubation of BMDC with Diprotin A, a reversible inhibitor of CD26 peptidase activity that enhances the stromal-derived factor-1 (SDF-1/CXCL12)/CXCR4 axis, resulted in a 30% increase in the percentage of CMFDA(+) cells retained in the lung.	diprotin A	27-37	chemokine (C-X-C motif) receptor 4	Mus musculus	147-152